Nebenwirkungen · Aptivus
Aptivus 250 mg soft capsules · Abschnitt 4.8 · PDF-Seite 26
HOS-114871 · Präparat HOS-094169
In HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic infections may arise. Autoimmune disorders (such as Graves’ disease and autoimmune hepatitis) have also been reported; however, the reported time to onset is more variable and these events can occur many months after initiation of treatment (see section 4.4). Reactivation of herpes simplex and herpes zoster virus infections were observed in the RESIST trials.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-23T09:35:00Z · SHA-256 1c396190f98e89933229f2261b0e436bd43dac9c1de8e2dacaa36a755dc06dce · Passage 19ff51d5a511a270149bd876081a11cd3478a6f0a3c770bc7c540d0417124511 · Zeichen 8343–8898 im Abschnitt